Similarly, in esophageal cancer, lung cancer, gastric cancer, and colorectal cancer, KRT17 knockout can inhibit cancer cell proliferation, migration, invasion, and colony formation and induce apoptosis (Chivu-Economescu et al., 2017; Wang et al., 2019; Liu et al., 2020; Ujiie et al., 2020). Here, KRT17 is linked to cancer.